Plant-Derived Chinese Medicine Monomers on Ovarian Cancer Via the Wnt/-Catenin Signaling Pathway: Review of Mechanisms and Prospects

Overview

Journal J Oncol

Specialty Oncology

Date 2021 Dec 16

PMID 34912456

Citations 5

Authors

Jia-Yue Xu

Fang-Yuan Liu

Shao-Xuan Liu

Liang-Zhen Xie

Jia Li

Yu-Ting Ma

Feng-Juan Han

Affiliations

Soon will be listed here.

Abstract

Ovarian cancer (OC) is a common malignant tumor of the female reproductive system and has a high morbidity and mortality rate. The progression and metastasis of OC are complex and involve multiple signaling pathways. The Wnt/-catenin signaling pathway is closely related to OC, and therefore blocking the activation of the Wnt/-catenin signaling directly or inhibiting related genes, and molecular targets is of great value in treating OC. Toxicities such as myelotoxicity, cardiotoxicity, genotoxicity, and vasospasm are the major side effects for common anticancer drugs and are well documented. There is, therefore, a need to develop new, effective, safer, and more affordable anticancer drugs from alternative sources. In recent years, plant-derived Chinese medicine monomers have drawn increasing attention due to their high safety, low toxicity, minimal side effects, and antitumor effects. Plant-derived Chinese medicine monomers are effective against multiple targets and can regulate the growth, proliferation, apoptosis, invasion, and migration of OC as well as reverse drug resistance by regulating the Wnt/-catenin signaling pathway. In this review, we summarize and provide mechanisms and prospects for the use of plant-derived Chinese medicines for the prevention and treatment of OC.

Citing Articles

Cytotoxic Activity of Curcumin- and Resveratrol-Loaded Core-Shell Systems in Resistant and Sensitive Human Ovarian Cancer Cells.

Wezgowiec J, Lapinska Z, Lamch L, Szewczyk A, Saczko J, Kulbacka J Int J Mol Sci. 2025; 26(1.

PMID: 39795900 PMC: 11720041. DOI: 10.3390/ijms26010041.

A specific super-enhancer actuated by berberine regulates EGFR-mediated RAS-RAF1-MEK1/2-ERK1/2 pathway to induce nasopharyngeal carcinoma autophagy.

Wu Y, Jia Q, Tang Q, Chen L, Deng H, He Y Cell Mol Biol Lett. 2024; 29(1):92.

PMID: 38943090 PMC: 11214260. DOI: 10.1186/s11658-024-00607-4.

Alcohol extract of : Metabolic alterations and preventive effects against OGD/R‑induced oxidative damage in HT22 cells.

Cheng J, Li G, Yang L, Chen P, Duan X Biomed Rep. 2024; 20(5):75.

PMID: 38544959 PMC: 10963945. DOI: 10.3892/br.2024.1763.

Icariin as a potential anticancer agent: a review of its biological effects on various cancers.

Liu F, Ding D, Wang Y, Liu S, Peng C, Shen F Front Pharmacol. 2023; 14:1216363.

PMID: 37456751 PMC: 10347417. DOI: 10.3389/fphar.2023.1216363.

ACY1 Downregulation Enhances the Radiosensitivity of Cetuximab-Resistant Colorectal Cancer by Inactivating the Wnt/β-Catenin Signaling Pathway.

Shan W, Dai C, Zhang H, Han D, Yi Q, Xia B Cancers (Basel). 2022; 14(22).

PMID: 36428796 PMC: 9688869. DOI: 10.3390/cancers14225704.

References

Hu W, Liu T, Ivan C, Sun Y, Huang J, Mangala L . Notch3 pathway alterations in ovarian cancer. Cancer Res. 2014; 74(12):3282-93. PMC: 4058356. DOI: 10.1158/0008-5472.CAN-13-2066. View

Doumpas N, Lampart F, Robinson M, Lentini A, Nestor C, Cantu C . TCF/LEF dependent and independent transcriptional regulation of Wnt/β-catenin target genes. EMBO J. 2018; 38(2). PMC: 6331726. DOI: 10.15252/embj.201798873. View

Wong S, Fang C, Chuah L, Leong C, Ching Ngai S . E-cadherin: Its dysregulation in carcinogenesis and clinical implications. Crit Rev Oncol Hematol. 2017; 121:11-22. DOI: 10.1016/j.critrevonc.2017.11.010. View

Auersperg N, Pan J, Grove B, Peterson T, Fisher J, Maines-Bandiera S . E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci U S A. 1999; 96(11):6249-54. PMC: 26867. DOI: 10.1073/pnas.96.11.6249. View

Li S, Li G, Liu L, Jiang X, Zhang B, Liu Z . Evaluation of paeonol skin-target delivery from its microsponge formulation: in vitro skin permeation and in vivo microdialysis. PLoS One. 2013; 8(11):e79881. PMC: 3835837. DOI: 10.1371/journal.pone.0079881. View

Mendonsa A, Na T, Gumbiner B . E-cadherin in contact inhibition and cancer. Oncogene. 2018; 37(35):4769-4780. PMC: 6119098. DOI: 10.1038/s41388-018-0304-2. View

Breuss J, Atanasov A, Uhrin P . Resveratrol and Its Effects on the Vascular System. Int J Mol Sci. 2019; 20(7). PMC: 6479680. DOI: 10.3390/ijms20071523. View

Mostowska A, Pawlik P, Sajdak S, Markowska J, Pawalowska M, Lianeri M . An analysis of polymorphisms within the Wnt signaling pathway in relation to ovarian cancer risk in a Polish population. Mol Diagn Ther. 2013; 18(1):85-91. PMC: 3899496. DOI: 10.1007/s40291-013-0059-y. View

Lin C, Chen H, Lin C, Wu H, Sheu J, Chen H . Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling. Sci Rep. 2017; 7(1):372. PMC: 5428476. DOI: 10.1038/s41598-017-00409-z. View

10.

Baczko I, Light P . Resveratrol and derivatives for the treatment of atrial fibrillation. Ann N Y Acad Sci. 2015; 1348(1):68-74. DOI: 10.1111/nyas.12843. View

11.

Zhu H, Zou X, Lin S, Hu X, Gao J . Effects of naringin on reversing cisplatin resistance and the Wnt/-catenin pathway in human ovarian cancer SKOV3/CDDP cells. J Int Med Res. 2020; 48(10):300060519887869. PMC: 7588763. DOI: 10.1177/0300060519887869. View

12.

Tian X, Liu Z, Niu B, Zhang J, Tan T, Lee S . E-cadherin/β-catenin complex and the epithelial barrier. J Biomed Biotechnol. 2011; 2011:567305. PMC: 3191826. DOI: 10.1155/2011/567305. View

13.

Gottardi C, Wong E, Gumbiner B . E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol. 2001; 153(5):1049-60. PMC: 2174337. DOI: 10.1083/jcb.153.5.1049. View

14.

Nusse R, Varmus H . Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell. 1982; 31(1):99-109. DOI: 10.1016/0092-8674(82)90409-3. View

15.

Pinho S, Seruca R, Gartner F, Yamaguchi Y, Gu J, Taniguchi N . Modulation of E-cadherin function and dysfunction by N-glycosylation. Cell Mol Life Sci. 2010; 68(6):1011-20. PMC: 11114786. DOI: 10.1007/s00018-010-0595-0. View

16.

Tran F, Zheng J . Modulating the wnt signaling pathway with small molecules. Protein Sci. 2017; 26(4):650-661. PMC: 5368067. DOI: 10.1002/pro.3122. View

17.

Zhang Y, Wang S, Dai M, Nai J, Zhu L, Sheng H . Solubility and Bioavailability Enhancement of Oridonin: A Review. Molecules. 2020; 25(2). PMC: 7024198. DOI: 10.3390/molecules25020332. View

18.

Foulquier S, Daskalopoulos E, Lluri G, Hermans K, Deb A, Blankesteijn W . WNT Signaling in Cardiac and Vascular Disease. Pharmacol Rev. 2017; 70(1):68-141. PMC: 6040091. DOI: 10.1124/pr.117.013896. View

19.

Nguyen V, Hough R, Bernaudo S, Peng C . Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis. J Ovarian Res. 2019; 12(1):122. PMC: 6905042. DOI: 10.1186/s13048-019-0596-z. View

20.

Vleminckx K, Vakaet Jr L, Mareel M, Fiers W, VAN Roy F . Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 1991; 66(1):107-19. DOI: 10.1016/0092-8674(91)90143-m. View